The Risky Race for a Quick Coronavirus Vaccine

Photo: NIAID

After bungling containment, the Trump administration hopes for a fast-tracked fix. But compressing trials comes with its own hazards.

As the coronavirus that causes Covid-19 sweeps across the world, scientists are racing to find vaccines that could stop the virus in its tracks.

On Monday, Moderna Therapeutics, a Massachusetts-based company, began the first human clinical trials of its vaccine in Seattle, Washington—skipping the typical phase of trials wherein a new vaccine or medication is tested on animals first.

A successful vaccine could be a lifesaver for many. But bioethicists are also concerned about the compressed timeline—and what it means for vaccine development in the future. Read more at The New Republic.

Categories: Freelance Articles

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 207 other subscribers

NBCC Member

%d bloggers like this: